M84.756S Complete transverse atypical femoral fracture, unspecified leg, sequela

Name of the Condition

• Complete Transverse Atypical Femoral Fracture, Unspecified Leg, Sequela (ICD-10-CM: M84.756S)

Summary

A complete transverse atypical femoral fracture, unspecified leg, sequela refers to the residual effects of a prior complete transverse atypical femoral fracture in the unspecified leg. This condition represents the long-term consequences of the fracture, such as chronic pain, functional impairment, or structural changes, following the healing phase. Atypical femoral fractures are distinct from typical osteoporotic fractures and often occur with minimal or no trauma, typically involving the subtrochanteric or diaphyseal region of the femur. The "sequela" designation indicates this is a chronic condition resulting from the original fracture.

Causes

Complete transverse atypical femoral fractures result from a combination of mechanical stress and impaired bone quality. Prolonged use of antiresorptive medications (e.g., bisphosphonates) is a well-documented cause, as these drugs may alter bone remodeling. Other contributing factors include metabolic bone disorders, vitamin D deficiency, or conditions that weaken bone structure, even in the absence of significant trauma. The sequela arises as a result of the initial fracture and its healing process.

Risk Factors

• Long-term use of antiresorptive or antiangiogenic medications.
• History of low-trauma fractures or osteoporosis.
• Vitamin D deficiency or calcium insufficiency.
• Chronic kidney disease or other metabolic disorders affecting bone health.
• Female gender, particularly postmenopausal individuals.

Symptoms

Symptoms of this sequela may include persistent thigh or groin pain, reduced mobility, difficulty bearing weight, and possible deformity or malunion of the femur. Patients may experience functional limitations, such as difficulty walking or performing daily activities, due to residual effects of the fracture.

Diagnosis

Diagnosis involves a thorough clinical evaluation, including a review of the patient’s medical history and prior fracture details. Imaging studies, such as X-rays or MRI, may be used to assess the residual bone structure, healing status, and any associated complications. The diagnosis is confirmed by identifying the sequela of the original atypical femoral fracture.

Treatment Options

Treatment focuses on managing symptoms and improving function. This may include pain management, physical therapy to restore mobility, and assistive devices (e.g., crutches or braces) to support weight-bearing. In some cases, surgical intervention may be considered to address structural abnormalities or improve alignment.

Prognosis and Follow-Up

The prognosis depends on the extent of residual damage and the patient’s overall health. Most patients experience improved function with appropriate management, though some may have persistent limitations. Regular follow-up is important to monitor for complications and adjust treatment as needed.

Complications

Potential complications include chronic pain, reduced mobility, malunion or nonunion of the fracture, and increased risk of future fractures. Patients may also experience psychological impacts, such as anxiety or depression, related to functional limitations.

Lifestyle & Prevention

Lifestyle modifications, such as maintaining a balanced diet rich in calcium and vitamin D, engaging in weight-bearing exercises, and avoiding high-impact activities, can support bone health. For patients with a history of atypical fractures, discontinuing or adjusting antiresorptive medications may be considered under medical supervision.

When to Seek Professional Help

Seek medical attention if you experience worsening pain, new swelling, difficulty moving the leg, or signs of infection (e.g., fever, redness) at the fracture site. Prompt evaluation is important to address any new complications or adjust treatment.

Tips for Medical Coders

When coding M84.756S, ensure the documentation clearly indicates the condition is a sequela of a prior complete transverse atypical femoral fracture in the unspecified leg. Verify that the encounter is for the residual effects of the fracture, not the acute phase or routine healing. Document the anatomical location (unspecified leg) and the nature of the sequela (e.g., chronic pain, functional impairment) to support accurate coding.